Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of Fc receptors in HIV prevention and therapy
Austin W. Boesch, Eric P. Brown, Margaret E. Ackerman
Immunological Reviews (2015) Vol. 268, Iss. 1, pp. 296-310
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Enhanced clearance of HIV-1–infected cells by broadly neutralizing antibodies against HIV-1 in vivo
Ching-Lan Lu, Dariusz K. Murakowski, Stylianos Bournazos, et al.
Science (2016) Vol. 352, Iss. 6288, pp. 1001-1004
Open Access | Times Cited: 325
Single-Domain Antibodies and Their Formatting to Combat Viral Infections
Dorien De Vlieger, Marlies Ballegeer, Iebe Rossey, et al.
Antibodies (2018) Vol. 8, Iss. 1, pp. 1-1
Open Access | Times Cited: 86
HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies
Simone I. Richardson, Amy W. Chung, Harini Natarajan, et al.
PLoS Pathogens (2018) Vol. 14, Iss. 4, pp. e1006987-e1006987
Open Access | Times Cited: 73
Systems serology for evaluation of HIV vaccine trials
Margaret E. Ackerman, Dan H. Barouch, Galit Alter
Immunological Reviews (2017) Vol. 275, Iss. 1, pp. 262-270
Open Access | Times Cited: 70
Progress and Challenges in HIV-1 Vaccine Research: A Comprehensive Overview
Alex Boomgarden, Chitra Upadhyay
Vaccines (2025) Vol. 13, Iss. 2, pp. 148-148
Open Access
Non-Neutralizing Antibodies Directed against HIV and Their Functions
Luzia Mayr, Bin Su, Christiane Moog
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 52
Neutralizing antibodies for HIV-1 prevention
Boris Jülg, Dan H. Barouch
Current Opinion in HIV and AIDS (2019) Vol. 14, Iss. 4, pp. 318-324
Open Access | Times Cited: 37
The potential of engineered antibodies for HIV-1 therapy and cure
Marloes Grobben, Richard AL Stuart, Marit J. van Gils
Current Opinion in Virology (2019) Vol. 38, pp. 70-80
Open Access | Times Cited: 36
Antibody-Dependent Cellular Phagocytosis of HIV-1-Infected Cells Is Efficiently Triggered by IgA Targeting HIV-1 Envelope Subunit gp41
Maxence Duchemin, Daniela Tudor, Andréa Cottignies-Calamarte, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 28
Mapping the interplay between NK cells and HIV: therapeutic implications
Renee R. Anderko, Robbie B. Mailliard
Journal of Leukocyte Biology (2023) Vol. 113, Iss. 2, pp. 109-138
Open Access | Times Cited: 9
Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field
Bruce D. Wines, Hugh Billings, Milla R. McLean, et al.
Current HIV Research (2017) Vol. 15, Iss. 3
Open Access | Times Cited: 29
Conserved HIV Epitopes for an Effective HIV Vaccine
Bikash Sahay, Cuong Q. Nguyen, Janet K. Yamamoto
Journal of Clinical & Cellular Immunology (2017) Vol. 08, Iss. 04
Open Access | Times Cited: 29
Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial
Shuying S. Li, Peter B. Gilbert, Lindsay N. Carpp, et al.
Journal of Virology (2019) Vol. 93, Iss. 21
Open Access | Times Cited: 27
Structural Basis for Epitopes in the gp120 Cluster A Region that Invokes Potent Effector Cell Activity
William D. Tolbert, Rebekah Sherburn, Verna Van, et al.
Viruses (2019) Vol. 11, Iss. 1, pp. 69-69
Open Access | Times Cited: 26
Pre-existing infant antibody-dependent cellular cytotoxicity associates with reduced HIV-1 acquisition and lower morbidity
Allison S. Thomas, Yvetane Moreau, Wenqing Jiang, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 10, pp. 100412-100412
Open Access | Times Cited: 20
eCD4-Ig promotes ADCC activity of sera from HIV-1-infected patients
Meredith E. Davis-Gardner, Matthew R. Gardner, Barnett Alfant, et al.
PLoS Pathogens (2017) Vol. 13, Iss. 12, pp. e1006786-e1006786
Open Access | Times Cited: 27
Susceptibility to Neutralization by Broadly Neutralizing Antibodies Generally Correlates with Infected Cell Binding for a Panel of Clade B HIV Reactivated from Latent Reservoirs
Yanqin Ren, Maria Korom, Ronald Truong, et al.
Journal of Virology (2018) Vol. 92, Iss. 23
Open Access | Times Cited: 26
Antibody Fc-chimerism and effector functions: When IgG takes advantage of IgA
Andréa Cottignies-Calamarte, Daniela Tudor, Morgane Bomsel
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Engineering broadly neutralizing antibodies for HIV prevention and therapy
Casey K. Hua, Margaret E. Ackerman
Advanced Drug Delivery Reviews (2016) Vol. 103, pp. 157-173
Open Access | Times Cited: 18
Antibody cooperative adsorption onto AuNPs and its exploitation to force natural killer cells to kill HIV-infected T cells
Antonio Astorga-Gamaza, Michele Vitali, Mireya L. Borrajo, et al.
Nano Today (2020) Vol. 36, pp. 101056-101056
Open Access | Times Cited: 16
Fc Receptors: Introduction
P. Mark Hogarth
Immunological Reviews (2015) Vol. 268, Iss. 1, pp. 1-5
Open Access | Times Cited: 15
Broadly neutralizing antibodies: An approach to control HIV-1 infection
Mahmoud Mohammad Yaseen, Mohammad Yaseen, Mohammad A. Y. Alqudah
International Reviews of Immunology (2016) Vol. 36, Iss. 1, pp. 31-40
Closed Access | Times Cited: 13
Antibody-dependent cellular cytotoxicity responses and susceptibility influence HIV-1 mother-to-child transmission
Allison S. Thomas, Carolyn Coote, Yvetane Moreau, et al.
JCI Insight (2022) Vol. 7, Iss. 9
Open Access | Times Cited: 8
Cell-targeting antibodies in immunity to Ebola
Alan Schmaljohn, George K. Lewis
Pathogens and Disease (2016) Vol. 74, Iss. 4, pp. ftw021-ftw021
Open Access | Times Cited: 12
The role of conventional antibodies targeting the CD4 binding site and CD4-induced epitopes in the control of HIV-1 CRF01_AE viruses
Win Thida, Takeo Kuwata, Yosuke Maeda, et al.
Biochemical and Biophysical Research Communications (2018) Vol. 508, Iss. 1, pp. 46-51
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top